Eisler Capital (UK)’s Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share NGC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,710
Closed -$12K 457
2021
Q3
$12K Buy
+12,710
New +$14.2K ﹤0.01% 342

Other funds holding NGC.WS

Eisler Capital (UK)'s NGC.WS Position: Q4 2021 in Review

Eisler Capital (UK) sold out of Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share (NGC.WS) in Q4 2021, closing a stake of 12,710 shares — an estimated $12K sold.

Eisler Capital (UK) first reported a position in NGC.WS in Q3 2021 and held it in 1 quarter. The position peaked at $12K in Q3 2021. 20 funds tracked by Wall St. Rank hold NGC.WS as of Q4 2021.

  • Eisler Capital (UK) reported no remaining Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share position as of Q4 2021 after selling out during the quarter.
  • Eisler Capital (UK) sold 12,710 Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share shares in Q4 2021, an estimated $12K.
  • Eisler Capital (UK) first reported a position in Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share in Q3 2021 and held it in 1 quarter.
  • Eisler Capital (UK)'s Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share position peaked at $12K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share as of Q4 2021.

Based on Eisler Capital (UK)'s 13F filing for Q4 2021, filed 14 Feb 2022.